Collaborating across the system and redesigning pharmacy services to optimise medicines value and improve outcomes
1 October 2024 | Leonardo Royal Hotel, London City
08.00 Registration & refreshments
08.50 Chair’s opening remarks - Alastair McLellan, Editor, HSJ
09.00 KEYNOTE: The National Picture for Medicines and Pharmacy
- With significant changes to the medicine and pharmacy landscape we hear from senior national leadership on key strategic priorities and the landscape, such as:
- Future of pharmacy services and the role of community pharmacy teams and independent prescribing in an integrated care environment of?
- The importance of patient-centred care and tailored medication management strategies to optimise health outcomes.
- How can effective collaboration between trusts, community pharmacy and ICS level regional strategy can effectively drive medicines optimisation
- The anticipated challenges such as rising healthcare costs and the need for innovation and collaboration to address them effectively.
- The strategic priorities for pharmacy practice, including expanding pharmacist roles in primary care and leveraging technology for enhanced patient outcomes.
- How are we developing digital transformation for pharmacy services?
09.45 PANEL: How do pharmacies play a crucial part in reducing variation and health inequalities?
- What is our main focus for improving prescribing?
- How can we improve efficiency and personalisation of medicines?
- How are ICBs monitoring Health Inequalities and how addressing them?
- How do we reduce unwarranted variation, fairer equity to access of medicines and improve patients experience?
- How do we collaborate and foster engagement from relevant stakeholders
- What would it take to have a national formulary to aid the reduction of health inequalities?
10.30 Morning refreshments & networking
11:00 PANEL: Maximising value and outcomes through formulary reviews
- Ensuring a holistic view of patient and population needs when creating evidence bases for first- and second-line prescribing decision making
- Finding ways to balance costs, outcome measures and patient experience to ensure the greatest patient benefit is gained each time
- Discussing why and how industry could facilitate better data sharing and evidence bases to inform decision making
- Continuously assessing the impact of formulary changes on prescribing patterns to maximise value
11:40 PANEL: Optimising outcomes through service digitization and interoperability
- What is the future of e-prescribing, including system-level implementation and legislative considerations?
- The importance of shared electronic health records for coordinated care delivery and patient safety.
- How is the role of technology in enhancing decision-making processes and prioritising healthcare resources?
- Address the need for universal access to digital healthcare systems, strategies for breaking down silos, and leveraging AI for improved patient care and outcomes.
12:20 Innovation Showcase
- AI and the impact on medicines
- Partner innovation Showcase
- Partner Innovation Showcase
12.50 Networking lunch
13:40 Interactive Workshops: 45 min interactive workshop sessions, with three running concurrently
- Empowering pharmacy teams: Future-proofing the pharmacy workforce
- Deprescribing and polypharmacy: How should progress be measured?
- How do we improve patient safety with medicines?
- Genomics Testing
- Challenges of manufacturing medicines on site / Homecare Infusion
- Optimising oncology pharmacy and prescribing and upskilling the pharmacy workforce
15:10 Afternoon refreshments & networking
15:40 PANEL: Pharmacy First: 6 Months in: How is it working so far?
- The framework for future commissioning of NHS Community Pharmacy
- How is Pharmacy First working so far in the community with a significant increased footfall into community pharmacy?
- Are we seeing the benefits in relieving pressures on GPs and primary care?
- How are we managing work force and training for independent prescribing
- Are there any teething problems in its implementation?
- How is this working with the ICS?
16:20 PANEL: How are we managing devolved responsibility for specialised commissioning?
- Case studies how services have been redesigned following delegation?
- How working with neighbouring ICS?
- How to manage the rising costs of medications within the context of specialised commissioning
- Strategies for prioritizing and allocating resources effectively
- How are we ensuring equitable access to specialised medications across different regions and patient populations can be challenging due to variations in funding, clinical criteria, and availability of treatments?
- Considerations for balancing the need for innovative treatments with budget constraints
17:20 Chair’s closing remarks